AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (256.7 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Interpretation of expert consensus on treatment for stage Ⅲ non‐small cell lung cancer

Weichi Luo1,2Riwei Zhong2,3Mingyi Yang2,3Qing Zhou2 ( )
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
School of Medicine South China University of Technology, Guangzhou, China
Show Author Information

References

【1】
【1】
 
 
Medicine Advances
Pages 89-91

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Luo W, Zhong R, Yang M, et al. Interpretation of expert consensus on treatment for stage Ⅲ non‐small cell lung cancer. Medicine Advances, 2023, 1(1): 89-91. https://doi.org/10.1002/med4.5

1291

Views

122

Downloads

2

Crossref

Published: 24 March 2023
© 2023 The Authors. Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.